References
Holland SM, Vinh DC. Yeast infections—human genetics on the rise. New Engl J Med. 2009;361:1798–801.
Puel A, Doffinger R, Natividad A, et al. Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J Exp Med. 2010;207:291–7.
Kisand K, Boe Wolff AS, Podkrajsek KT, et al. Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines. J Exp Med. 2010;207:299–308.
Minegishi Y, Saito M, Nagasawa M, et al. Molecular explanation for the contradiction between systemic Th17 defect and localized bacterial infection in hyper-IgE syndrome. J Exp Med. 2009;206:1291–301.
Ferwerda B, Ferwerda G, Plantinga TS, et al. Human dectin-1 deficiency and mucocutaneous fungal infections. New Engl J Med. 2009;361:1760–7.
Glocker E-O, Hennigs A, Nabavi M, et al. A homozygous CARD9 mutation in a family with susceptibility to fungal infections. New Engl J Med. 2009;361:1727–35.
de Beaucoudrey L, Puel A, Filipe-Santos O, et al. Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. J Exp Med. 2008;205(7):1543–50.
Wells RS, Higgs JM, Macdonald A, et al. Familial chronic muco-cutaneous candidiasis. J Med Genet. 1972;9(3):302–10.
Canales L, Middlemas 3rd RO, Louro JM, et al. Immunological observations in chronic mucocutaneous candidiasis. Lancet. 1969;294:567–71.
Korn T, Bettelli E, Oukka M, et al. IL-17 and Th17 cells. Annu Rev Immunol. 2009;27:485–517.
Aujla SJ, Dubin PJ, Kolls JK. Th17 cells and mucosal host defense. Semin Immunol. 2007;19:377–82.
Hueber W, Patel DD, Dryja T, et al. Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis. Sci Transl Med. 2010;2:52ra72.
Wang YH, Voo KS, Liu B, et al. A novel subset of CD4+ TH2 memory/effector cells that produce inflammatory IL-17 cytokine and promote the exacerbation of chronic allergic asthma. J Exp Med. 2010;207:2479–91.
Martinez-Moczygemba M, Doan ML, Elidemir O, et al. Pulmonary alveolar proteinosis caused by deletion of the GM-CSFRalpha gene in the X chromosome pseudoautosomal region 1. J Exp Med. 2008;205:2711–6.
Takuji S, Sakagami T, Rubin BK, et al. Familial pulmonary proteinosis caused by mutations in CSF2RA. J Exp Med. 2008;205:2703–10.
Kitamura T, Tanaka N, Watanabe K, et al. Idiopathic pulmonary proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony stimulating factor. J Exp Med. 1999;190:875–80.
Martinez-Moczygemba M, Huston DP. Immune dysregulation in the pathogenesis of pulmonary alveolar proteinosis. Curr Allergy Asthma Rep. 2010;10:320–5.
van de Veerdonk FL, Plantinga TS, Hoischen A, et al. STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. N Engl J Med. 2011;365:54-61.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Huston, D.P. Defects in Interleukin-17 Immunity in the Pathogenesis of Chronic Mucocutaneous Candidiasis. Curr Allergy Asthma Rep 11, 342–344 (2011). https://doi.org/10.1007/s11882-011-0209-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11882-011-0209-4